BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou L, Wang K, Li Q, Nice EC, Zhang H, Huang C. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives. Expert Rev Proteomics 2016;13:367-81. [PMID: 26923776 DOI: 10.1586/14789450.2016.1159959] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Gupta SL, Basu S, Soni V, Jaiswal RK. Immunotherapy: an alternative promising therapeutic approach against cancers. Mol Biol Rep 2022. [PMID: 35759082 DOI: 10.1007/s11033-022-07525-8] [Reference Citation Analysis]
2 Ahmed Z. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities. Emerg Top Life Sci 2022:ETLS20210244. [PMID: 35234253 DOI: 10.1042/ETLS20210244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). World J Gastrointest Pathophysiol 2022; 13(1): 1-14 [PMID: 35116176 DOI: 10.4291/wjgp.v13.i1.1] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang WT, Liu TT, Wu M, Chen XC, Han L, Shi ZZ, Li YY, Li XY, Xu HX, Gong LK, Xu PH, Geng Y. Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1. Acta Pharmacol Sin 2021;42:1921-9. [PMID: 33633363 DOI: 10.1038/s41401-020-00574-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang Y, Guo W, Xie S, Liu Y, Xu D, Chen G, Xu Y. Multi-omics analysis of brain tissue metabolome and proteome reveals the protective effect of gross saponins of Tribulus terrestris L. fruit against ischemic stroke in rat. J Ethnopharmacol 2021;278:114280. [PMID: 34082014 DOI: 10.1016/j.jep.2021.114280] [Reference Citation Analysis]
6 Tao H, Zuo L, Xu H, Li C, Qiao G, Guo M, Lin X. Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years. Recent Pat Anticancer Drug Discov 2020;15:2-13. [PMID: 32003702 DOI: 10.2174/1574892815666200131120618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Vaysse PM, Grabsch HI, van den Hout MFCM, Bemelmans MHA, Heeren RMA, Olde Damink SWM, Porta Siegel T. Real-time lipid patterns to classify viable and necrotic liver tumors. Lab Invest 2021;101:381-95. [PMID: 33483597 DOI: 10.1038/s41374-020-00526-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Giudice G, Petsalaki E. Proteomics and phosphoproteomics in precision medicine: applications and challenges. Brief Bioinform 2019;20:767-77. [PMID: 29077858 DOI: 10.1093/bib/bbx141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
9 Zhang T, Li S, Warden AR, Ghalandari B, Li H, Zhi X, Xie H, Ding X. A Photoclick Hydrogel for Enhanced Single‐Cell Immunoblotting. Adv Funct Mater 2020;30:1910739. [DOI: 10.1002/adfm.201910739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Paul P, Muthu M, Chilukuri Y, Haga SW, Chun S, Oh J. In Silico Tools and Phosphoproteomic Software Exclusives. Processes 2019;7:869. [DOI: 10.3390/pr7120869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wermuth PJ, Piera-Velazquez S, Rosenbloom J, Jimenez SA. Existing and novel biomarkers for precision medicine in systemic sclerosis. Nat Rev Rheumatol 2018;14:421-32. [PMID: 29789665 DOI: 10.1038/s41584-018-0021-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
12 Duan B, Hu X, Fan M, Xiong X, Han L, Wang Z, Tong D, Liu L, Wang X, Li W, Yang J, Huang C. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer. Proteomics Clin Appl 2019;13:e1900048. [PMID: 31207145 DOI: 10.1002/prca.201900048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Cho W, Kim JH, Jeong M, Kim MS, Lee J, Son H, Cheon C, Park S, Ko SG. Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine. Medicine (Baltimore) 2019;98:e16035. [PMID: 31192960 DOI: 10.1097/MD.0000000000016035] [Reference Citation Analysis]
14 An Y, Zhou L, Huang Z, Nice EC, Zhang H, Huang C. Molecular insights into cancer drug resistance from a proteomics perspective. Expert Rev Proteomics 2019;16:413-29. [PMID: 30925852 DOI: 10.1080/14789450.2019.1601561] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
15 Naugler C, Church DL. Clinical laboratory utilization management and improved healthcare performance. Critical Reviews in Clinical Laboratory Sciences 2019;55:535-47. [DOI: 10.1080/10408363.2018.1526164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lucas N, Robinson AB, Marcker Espersen M, Mahboob S, Xavier D, Xue J, Balleine RL, deFazio A, Hains PG, Robinson PJ. Accelerated Barocycler Lysis and Extraction Sample Preparation for Clinical Proteomics by Mass Spectrometry. J Proteome Res 2018. [DOI: 10.1021/acs.jproteome.8b00684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kyriazis M. Four Principles Regarding an Effective Treatment of Aging. Curr Aging Sci 2018;11:149-54. [PMID: 30362423 DOI: 10.2174/1874609811666181025170059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Duan B, Bai J, Qiu J, Wang J, Tong C, Wang X, Miao J, Li Z, Li W, Yang J, Huang C. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients. EBioMedicine 2018;37:134-43. [PMID: 30361067 DOI: 10.1016/j.ebiom.2018.10.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA Jr, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut 2018;67:1168-80. [PMID: 29437869 DOI: 10.1136/gutjnl-2017-315537] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 27.5] [Reference Citation Analysis]
20 Thomford NE, Dzobo K, Chimusa E, Andrae-marobela K, Chirikure S, Wonkam A, Dandara C. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 2018;22:375-91. [DOI: 10.1089/omi.2018.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
21 Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer 2018;9:1773-81. [PMID: 29805703 DOI: 10.7150/jca.24577] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 33.0] [Reference Citation Analysis]
22 Lim LC, Lim YM. Proteome Heterogeneity in Colorectal Cancer. Proteomics 2018;18. [PMID: 29316255 DOI: 10.1002/pmic.201700169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Katoh M. The integration of genomics testing and functional proteomics in the era of personalized medicine. Expert Rev Proteomics 2017;14:1055-8. [PMID: 29039218 DOI: 10.1080/14789450.2017.1392245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Yoo BC, Kim KH, Woo SM, Myung JK. Clinical multi-omics strategies for the effective cancer management. J Proteomics 2018;188:97-106. [PMID: 28821459 DOI: 10.1016/j.jprot.2017.08.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
25 Jain A, Jahagirdar D, Nilendu P, Sharma NK. Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics. Expert Review of Anticancer Therapy 2017;17:815-25. [DOI: 10.1080/14737140.2017.1356231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Yang J, Nishihara R, Zhang X, Ogino S, Qian ZR. Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer? J Diabetes Complications. 2017;31:1228-1236. [PMID: 28465145 DOI: 10.1016/j.jdiacomp.2017.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
27 Peukert M, Lim WL, Seiffert U, Matros A. Mass Spectrometry Imaging of Metabolites in Barley Grain Tissues. Current Protocols in Plant Biology 2016;1:574-91. [DOI: 10.1002/cppb.20037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Hamada T, Keum N, Nishihara R, Ogino S. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol. 2017;52:265-275. [PMID: 27738762 DOI: 10.1007/s00535-016-1272-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 12.2] [Reference Citation Analysis]
29 Alnabulsi A, Murray GI. Integrative analysis of the colorectal cancer proteome: potential clinical impact. Expert Rev Proteomics 2016;13:917-27. [PMID: 27598033 DOI: 10.1080/14789450.2016.1233062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]